Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

METH-RENAL: A Prospective Clinical Development and Threshold-Setting Study of a Plasma DNA Methylation Classifier for the Preoperative Evaluation of Renal Masses

NCT07874542 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT07874542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07874542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
METH-RENAL: A Prospective Clinical Development and Threshold-Setting Study of a Plasma DNA Methylation Classifier for the Preoperative Evaluation of Renal Masses
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2026
Completion date
June 30, 2027
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign renal mass, renal cell carcinoma